ORIENTCEMNSEOrient Cement Limited· Cement & Cement ProductsHighNeutral
Announced Wed, 2 Apr, 2025 · 14:57 IST

Orient Cement Limited has informed the Exchange about Action(s) taken or orders passed

ORIENTCEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+1.9%Reaction day
₹340.50
prior close
₹345.30
announcement price
In-mkt
timing
Nifty Microcap 250market · index membership as recorded later (tracked since Jun 2026)+0.7%+1.2% vs market
Cement & Cement Products peers, median of 34sector+0.7%+1.2% vs sector

On the reaction day the stock moved 1.2 pts more than Nifty Microcap 250 and 1.2 pts more than its Cement & Cement Products peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
-0.2
10m
+0.3
15m
+0.1
30m
+0.5
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+1.9+0.7+1.2+0.7+1.2
Next day
+3.2+1.7+1.5+2.4+0.8
2d
+2.7-2.0+4.7+0.4+2.3
3d
+3.0-6.2+9.2-1.4+4.4
4d
+3.6-4.0+7.6-0.5+4.1
5d
+4.7-5.2+9.9-1.4+6.1
1w
+5.7+1.2+4.4+2.8+2.8
15d
+3.4+2.9+0.5+3.8-0.4
1m
+2.7+0.4+2.3+1.4+1.3
2m
+2.4+12.8-10.3+5.0-2.6
3m
-29.1+16.0-45.0+12.4-41.5
UpDownMarket · Nifty Microcap 250Sector · Cement & Cement Products peers, median of 34Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Orient Cement Limited has filed a disclosure with the NSE stating that it has informed the exchange about certain action(s) taken or orders passed. The publicly available headline does not specify which authority issued the order, the nature of the action, or any financial impact. Without access to the full document text, the specifics of the matter — such as the issuing body, penalty amount, or compliance requirement — cannot be confirmed. Shareholders would need to review the full filing or the company's detailed communication for clarity on the underlying issue.

Likely market impact

The vague nature of the headline makes it difficult to assess any immediate impact on the stock price or shareholders. Investors should watch for a follow-up disclosure with concrete details to judge whether this is a routine compliance update or a material negative development.